8Q7O image
Entry Detail
PDB ID:
8Q7O
Title:
Crystal structure of the FZD3 cysteine-rich domain in complex with a nanobody (14478)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-08-16
Release Date:
2024-08-28
Method Details:
Experimental Method:
Resolution:
1.76 Å
R-Value Free:
0.22
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Nanobody 14478
Chain IDs:A, B
Chain Length:124
Number of Molecules:2
Biological Source:Lama glama
Polymer Type:polypeptide(L)
Description:Frizzled-3
Chain IDs:C, D
Chain Length:124
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Structural insights into Frizzled3 through nanobody modulators.
Nat Commun 15 7228 7228 (2024)
PMID: 39174501 DOI: 10.1038/s41467-024-51451-1

Abstact

The Wnt receptor Frizzled3 (FZD3) is important for brain axonal development and cancer progression. We report structures of FZD3 in complex with extracellular and intracellular binding nanobodies (Nb). The crystal structure of Nb8 in complex with the FZD3 cysteine-rich domain (CRD) reveals that the nanobody binds at the base of the lipid-binding groove and can compete with Wnt5a. Nb8 fused with the Dickkopf-1 C-terminal domain behaves as a FZD3-specific Wnt surrogate, activating β-catenin signalling. The cryo-EM structure of FZD3 in complex with Nb9 reveals partially resolved density for the CRD, which exhibits positional flexibility, and a transmembrane conformation that resembles active GPCRs. Nb9 binds to the cytoplasmic region of FZD3 at the putative Dishevelled (DVL) or G protein-binding site, competes with DVL binding, and inhibits GαS coupling. In combination, our FZD3 structures with nanobody modulators map extracellular and intracellular interaction surfaces of functional, and potentially therapeutic, relevance.

Legend

Protein

Chemical

Disease

Primary Citation of related structures